Title: Atacand Client: AstraZeneca Industry: Pharmaceutical Manufacturing Purpose: Product sales training

The challenge:
AstraZeneca's release of the new blockbuster drug, Atacand, into the complex pharmaceutical market called for a training solution beyond the traditional resource manual.

The solution had to educate and train 150 sales representatives about the features of this new product, and

• be cost-effective for rolling out to a national sales force
  
• be built on specific training and educational goals and techniques
  
• have the ability to identify learners' areas of difficulty
  
• incorporate tools for measuring success
  
• meet a tight timeline

The rainmaker's response:
DRI produced a comprehensive learning kit for sales representatives, featuring:

• interactive exercises
  
• detailed animation
  
• feedback and testing sections
  
• cross-references to the product resource manual
  
• comprehensive subject data

What this meant to AstraZeneca

• high user satisfaction
  
• excellent understanding of the new drug and its effects
  
• an effective sales force
  
• significantly reduced training costs
  
• increase compliance